Кристи Фанк - Грудь. Руководство пользователя [litres]

T. R. Rebbeck et al., “Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction after Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group,” Journal of Clinical Oncology 23, no. 31 (2005): 7804–7810.

K. Armstrong et al., “Hormone Replacement Therapy and Life Expectancy after Prophylactic Oophorectomy in Women with BRCA 1/2 Mutations: A Decision Analysis,” Journal of Clinical Oncology 22, no. 6 (2004): 1045–1054. Глава восьмая. Скрининг и обнаружение рака груди

J. P. Kösters and P. C. Gøtzsche, “Regular Self-Examination or Clinical Examination for Early Detection of Breast Cancer,” Cochrane Database of Systematic Reviews 2 (2003).

T. Roeke et al., “The Additional Cancer Yield of Clinical Breast Examination in Screening of Women at Hereditary Increased Risk of Breast Cancer: A Systematic Review,” Breast Cancer Research and Treatment 147, no. 1 (2014): 15–23.

F. D. Schwab et al., “Self-Detection and Clinical Breast Examination: Comparison of the Two “Classical” Physical Examination Methods for the Diagnosis of Breast Cancer,” The Breast 24, no. 1 (2015): 90–92.

B. L. Sprague et al., “National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from The Breast Cancer Surveillance Consortium,” Radiology 283, no. 1 (2017): 59–69.

S. Sayed et al., “Training Health Workers in Clinical Breast Examination for Early Detection of Breast Cancer in Low‐ and Middle‐Income Countries,” The Cochrane Library (2017).

B. C. R. Devi, T. S. Tang, and M. Corbex, “Reducing by Half the Percentage of Late-Stage Presentation for Breast and Cervix Cancer over 4 Years: A Pilot Study of Clinical Downstaging in Sarawak, Malaysia,” Annals of Oncology 18, no. 7 (2007): 1172–1176.

M. G. Marmot et al., “The Benefits and Harms of Breast Cancer Screening – An Independent Review: A Report Jointly Commissioned by Cancer Research U. K. and the Department of Health (England) October 2012,” British Journal of Cancer 108, no. 11 (2013): 2205.

K. L. Kummerow et al., “Nationwide Trends in Mastectomy for Early-Stage Breast Cancer,” JAMA Surgery 150 (2015): 9–16; S. T. Hawley et al., “Social and Clinical Determinants of Contralateral Prophylactic Mastectomy,” JAMA Surgery 149 (2014): 582–589.

C. P. McPherson, K. K. Swenson, and M. W. Lee, “The Effects of Mammographic Detection and Comorbidity on the Survival of Older Women with Breast Cancer,” Journal of the American Geriatrics Society 50, no. 6 (2002): 1061–1068.

M. M. Eberl et al., “BI-RADS Classification for Management of Abnormal Mammograms,” The Journal of the American Board of Family Medicine 19, no. 2 (2006): 161–164.

P. A. Carney et al., “Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography,” Annals of Internal Medicine 138 (2003): 168–175.

B. L. Sprague et al., “National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from The Breast Cancer Surveillance Consortium,” Radiology 283, no. 1 (2017): 59–69.

S. H. Taplin et.al., “Reason for Late-Stage Breast Cancer: Absence of Screening or Detection, or Breakdown in Follow-Up?” Journal of the National Cancer Institute 96, no. 20 (October 2004): 1518–1527.

L. Tabar et al., “Mammography Service Screening and Mortality in Breast Cancer Patients: 20-year Follow-Up before and after Introduction of Screening,” The Lancet 361, no. 9367 (2003): 1405–1410.

D. R. Youlden et al., “Incidence and Mortality of Female Breast Cancer in the Asia-Pacific Region,” Cancer Biology and Medicine 11 (2014): 101–115.

R. A. Smith et al., “The Randomized Trials of Breast Cancer Screening: What Have We Learned?” Radiologic Clinics of North America 42, no. 5 (2004): 793–806; M. Broeders et al., “The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Observational Studies,” Journal of Medical Screening 19, no. 1 (2012): 14–25; Preventive Services Task Force, “Screening for Breast Cancer: Recommendations and Rationale,” Annals of Internal Medicine 137 (2002): 344–346; D. A. Berry, “Benefits and Risks of Screening Mammography for Women in their Forties: A Statistical Appraisal,” Journal of the National Cancer Institute 90 (1998): 1431–1439.

E. D. Pisano et al., “Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening,” New England Journal of Medicine 353, no. 17 (October 2005): 1773–1783.

S. Ciatto et al., “Integration of 3D Digital Mammography with Tomosynthesis for Population Breast-Cancer Screening (STORM): A Prospective Comparison Study,” The Lancet Oncology 14 (2013): 583–589.

A. S. Tagliafico et al., “Diagnostic Performance of Contrast-Enhanced Spectral Mammography: Systematic Review and Meta-analysis,” The Breast 28 (2016): 13–19.

E. M. Fallenberg et al., “Contrast-Enhanced Spectral Mammography versus MRI: Initial Results in the Detection of Breast Cancer and Assessment of Tumour Size,” European Radiology 24, no. 1 (2014): 256–264.

P. A. Carney et al., “Factors Associated with Imaging and Procedural Events Used to Detect Breast Cancer after Screening Mammography,” American Journal of Roentgenology 188, no. 2 (2007): 385–392.

J. G. Elmore et al., “Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations,” New England Journal of Medicine 338, no. 16 (April 1998): 1089–1096.

S. Törnberg et al., “A Pooled Analysis of Interval Cancer Rates in Six European Countries,” European Journal of Cancer Prevention 19, no. 2 (2010): 87–93.

P. A. Carney et al., “Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography,” Annals of Internal Medicine 138, no. 3 (2003): 168–175; T. M. Kolb, J. Lichy, and J. H. Newhouse, “Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations,” Radiology 225, no. 1 (2002): 165–175.

S. S. K. Tang and G. P. H. Gui, “A Review of the Oncologic and Surgical Management of Breast Cancer in the Augmented Breast: Diagnostic, Surgical and Surveillance Challenges,” Annals of Surgical Oncology 18, no. 8 (2011): 2173–2181.